Your browser doesn't support javascript.
loading
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer.
Yang, Hanshen; Zhang, Xiaozhen; Lao, Mengyi; Sun, Kang; He, Lihong; Xu, Jian; Duan, Yi; Chen, Yan; Ying, Honggang; Li, Muchun; Guo, Chengxiang; Lu, Qingsong; Wang, Sicheng; Su, Wei; Liang, Tingbo; Bai, Xueli.
Affiliation
  • Yang H; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Zhang X; Zhejiang Provincial Key Laboratory of Pancreatic Disease, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Lao M; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, Zhejiang, China.
  • Sun K; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, China.
  • He L; Zhejiang University Cancer Center, Hangzhou, Zhejiang, China.
  • Xu J; Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, Zhejiang, China.
  • Duan Y; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Chen Y; Zhejiang Provincial Key Laboratory of Pancreatic Disease, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Ying H; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, Zhejiang, China.
  • Li M; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, China.
  • Guo C; Zhejiang University Cancer Center, Hangzhou, Zhejiang, China.
  • Lu Q; Research Center for Healthcare Data Science, Zhejiang Lab, Hangzhou, Zhejiang, China.
  • Wang S; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Su W; Zhejiang Provincial Key Laboratory of Pancreatic Disease, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Liang T; Innovation Center for the Study of Pancreatic Diseases, Hangzhou, Zhejiang, China.
  • Bai X; Zhejiang Clinical Research Center of Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, China.
Cell Death Differ ; 30(2): 560-575, 2023 02.
Article in En | MEDLINE | ID: mdl-36539510
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Death Differ Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / CD8-Positive T-Lymphocytes Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cell Death Differ Year: 2023 Document type: Article Affiliation country: Country of publication: